in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Mylan Welcomes FDA Safety and Innovation Act
10:10 AM MDT | July 10, 2012 | Deepti Ramesh
Mylan (Canonsburg, PA) says it applauds President Barack Obama’s signing of the Food and Drug Administration Safety and Innovation Act, legislation that will significantly enhance the safety and security of the U.S. drug supply chain, level the playing field to hold all drug manufacturers to FDA's inspection standards, and improve timely access to high-quality, affordable generic drugs. “Mylan has long been a passionate leader and advocate for many of the key provisions included in this important piece of legislation that will help...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee